Education
About Us
Working with TipRanks
Follow Us
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.01T | ¥ 964.99B | ¥ 827.70B | ¥ 755.41B | ¥ 726.42B |
| Gross Profit | ¥ 213.28B | ¥ 188.31B | ¥ 168.72B | ¥ 151.45B | ¥ 145.11B |
| Operating Income | ¥ 40.40B | ¥ 31.50B | ¥ 30.13B | ¥ 29.80B | ¥ 33.15B |
| EBITDA | ¥ 64.86B | ¥ 53.74B | ¥ 50.19B | ¥ 48.21B | ¥ 46.93B |
| Net Income | ¥ 30.98B | ¥ 24.45B | ¥ 23.80B | ¥ 23.16B | ¥ 27.16B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 57.04B | ¥ 52.30B | ¥ 45.93B | ¥ 37.36B | ¥ 55.11B |
| Total Assets | ¥ 524.75B | ¥ 476.55B | ¥ 420.97B | ¥ 363.05B | ¥ 341.32B |
| Total Debt | ¥ 49.96B | ¥ 34.06B | ¥ 18.20B | ¥ 9.41B | ¥ 10.44B |
| Net Debt | ¥ -7.08B | ¥ -18.24B | ¥ -27.73B | ¥ -27.95B | ¥ -44.66B |
| Total Liabilities | ¥ 267.29B | ¥ 245.10B | ¥ 209.90B | ¥ 172.54B | ¥ 170.74B |
| Stockholders' Equity | ¥ 257.46B | ¥ 231.44B | ¥ 211.07B | ¥ 190.51B | ¥ 170.58B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -859.00M | ¥ -859.00M | ¥ -635.00M | ¥ 7.80B | ¥ -11.30B |
| Operating Cash Flow | ¥ 52.47B | ¥ 52.47B | ¥ 55.17B | ¥ 54.43B | ¥ 32.19B |
| Investing Cash Flow | ¥ -55.45B | ¥ -55.45B | ¥ -57.33B | ¥ -49.11B | ¥ -43.72B |
| Financing Cash Flow | ¥ 7.72B | ¥ 7.72B | ¥ 8.53B | ¥ 3.25B | ¥ -6.22B |